| Literature DB >> 36249602 |
Abstract
BACKGROUND: Drug overdose is a medico-social issue worldwide that may occur intentionally or unintentionally. It is one of the most common reasons for emergency department visits, and it is also a frequent cause of morbidity and mortality globally. This study aims to determine the occurrence of acute toxicity cases and their management outcomes at the emergency departments in Qassim Province hospitals in Saudi Arabia. In addition, the study aims to investigate the antidote availabilities at those medical centers.Entities:
Keywords: acute toxicity; antidotes; drugs; emergency department; toxicity
Year: 2022 PMID: 36249602 PMCID: PMC9548525 DOI: 10.7759/cureus.28992
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Sociodemographic data of the acute toxicity cases treated in Qassim hospitals during 2020.
| Age groups | Males no. (%) | Females no. (%) | Total no. (%) | |
| 1 | 1-10 years | 9 (5%) | 5 (5.9%) | 14 (5.3%) |
| 2 | 11-20 years | 34 (19%) | 17 (20%) | 51 (19.3%) |
| 3 | 21-30 years | 32 (17.9%) | 14 (16.5%) | 46 (17.4%) |
| 4 | 31-40 years | 31 (17.3%) | 9 (10.6%) | 40 (15.2%) |
| 5 | 41-50 years | 28 (15.6%) | 8 (9.4%) | 36 (13.6%) |
| 6 | 51-60 years | 20 (11.2%) | 12 (14.1%) | 32 (12.1%) |
| 7 | 61-70 years | 16 (8.9%) | 11 (12.9%) | 27 (10.2%) |
| 8 | >70 years | 9 (5%) | 9 (10.6%) | 18 (6.8%) |
| Number of acute toxicity cases treated in urban and rural hospitals, respectively | ||||
| 1 | Urban | 236 (89.4%) | ||
| 2 | Rural | 28 (10.6%) | ||
| Hospital sector-treated acute toxicity cases | ||||
| 1 | Public | 250 (94.7%) | ||
| 2 | Private | 14 (5.3%) | ||
Figure 1Percentage of the acute toxicity cases managed in the different emergency departments of Qassim hospitals.
Figure 2Frequency of the different types of acute toxicity cases diagnosed in the emergency departments of Qassim hospitals during 2020.
Frequencies of clinical symptoms presented by the acute poisoning cases at the time of admission to the emergency medical departments of Qassim hospitals.
GIT, gastrointestinal tract
| S. No. | Clinical symptoms presented during the admission | No. of cases (%) |
| 1 | Vomiting and diarrhea + GIT disturbance | 57 (21.6%) |
| 2 | Bleeding | 42 (15.9%) |
| 3 | Hyperglycemia/Hypoglycemia | 34 (12.9%) |
| 4 | Liver impairment symptoms | 27 (10.2%) |
| 5 | Confusion | 20 (7.6%) |
| 6 | Abdominal pain | 14 (5.3%) |
| 7 | Palpitations/tachycardia | 13 (4.9%) |
| 8 | Deep sedation | 9 (3.4%) |
| 9 | Coma | 9 (3.4%) |
| 10 | Dizziness | 7 (2.7%) |
| 11 | Elevated blood pressure/hypotension | 4 (1.5%) |
| 12 | Increased saliva and tear production, constricted pupils, sweating, muscle tremors, and confusion | 4 (1.5%) |
| 13 | Constipation | 2 (0.8%) |
| 14 | Others | 22 (8.3%) |
Figure 3Frequency of the used antidotes and medications for the management of acute toxicity cases in the emergency departments of Qassim hospitals.
Availability of different antidotes and medications in participating Qassim hospitals during 2020.
EDTA, ethylene diamine tetraacetic acid
| No. | Name of antidote | Availability in hospitals no. (%) | No. | Name of antidote | Availability in hospitals no. (%) |
| 1 | Activated charcoal | 14 (100) | 18 | Insulin | 14 (100) |
| 2 | Atropine | 14 (100) | 91 | Isoproterenol | 7 (50) |
| 3 | Calcium chloride | 14 (100) | 20 | Leucovorin | 1 (7.1) |
| 4 | Calcium gluconate | 14 (100) | 21 | Magnesium | 14 (100) |
| 5 | Cholestyramine | 5 (35.7) | 22 | Methylene blue | 1 (7.1) |
| 6 | Cyanide kit | 0 (0) | 23 | N-Acetylcysteine (NAC) | 14 (100) |
| 7 | D50W | 13 (92.9) | 24 | Naloxone | 14 (100) |
| 8 | Deferoxamine | 7 (50) | 25 | Octreotide | 7 (50) |
| 9 | Digoxin immune F | 10 (71.4) | 26 | Hydroxocobalamin | 6 (42.9) |
| 10 | Dimercaprol | 2 (14.3) | 27 | Physostigmine/Pyridostigmine | 10 (71.4) |
| 11 | EDTA | 0 (0) | 28 | Pralidoxime | 9 (64.3) |
| 12 | Ethyl alcohol (ethanol) | 3 (21.4) | 29 | Protamine sulfate | 13 (92.9) |
| 13 | Flumazenil | 14 (100) | 30 | Pyridoxine | 8 (57.1) |
| 14 | Folic acid | 11(78.6) | 31 | Sodium bicarbonate | 14 (100) |
| 15 | Fomepizole | 2 (14.3) | 32 | Sodium nitrite | 6 (42.9) |
| 16 | Glucagon | 10 (71.4) | 33 | Sodium thiosulfate | 2 (14.3) |
| 17 | Glucose | 8 (75.1) | 34 | Vitamin K | 14 (100) |